Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America

International Journal of Antimicrobial Agents

Volumn 27, Issue 5, 2006, Pages 392-396

  Nichol, Kimberly A ^a   Sill, Michelle ^b   Laing, Nancy M ^b   Johnson, Jack L ^c   Hoban, Daryl J ^a,b,c   Zhanel, George G ^a,b  

^a HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c International Health Management Associates Inc   (United States)

Author keywords

Enterococcus faecium; Pulsed field gel electrophoresis; Urinary tract; Vancomycin resistant

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; GENTAMICIN; LINEZOLID; NITROFURANTOIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROCOCCUS FAECIUM; GEOGRAPHY; IN VITRO STUDY; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY HEALTH CARE; UNITED STATES; URINARY TRACT; VANCOMYCIN RESISTANT ENTEROCOCCUS; DRUG EFFECT; EPIDEMIOLOGY; GENETICS; HUMAN; MICROBIOLOGY; PHYLOGENY; URINARY TRACT INFECTION;

CANADA; ENTEROCOCCUS FAECIUM; EPIDEMIOLOGY, MOLECULAR; HUMANS; PHYLOGENY; UNITED STATES; URINARY TRACT INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 33646129918     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.12.005     Document Type: Article

References (10)

1. Murray B.E. Vancomycin-resistant enterococcal infections. N Engl J Med 342 (2000) 710-721
2. Gold H.S. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis 33 (2001) 210-219
3. Centres for Disease Control and Prevention (CDC). Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 42 (1993) 597-599
4. Zhanel G.G., Laing N.M., Nichol K.A., et al. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). J Antimicrob Chemother 52 (2003) 382-388
5. Evers S., Quintiliani Jr. R., and Courvalin P. Genetics of glycopeptide resistance in enterococci. Microb Drug Resist 2 (1996) 219-223
6. Cetinkaya Y., Falk P., and Mayhall C.G. Vancomycin-resistant enterococci. Clin Microbiol Rev 13 (2000) 686-707
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. 5th ed. (2000), NCCLS, Wayne, PA
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Tenth Informational Supplement M100-S10 (2000), NCCLS, Wayne, PA
9. Murray B.E., Singh K.V., Heath J.D., et al. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 28 (1990) 2059-2063
10. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239